SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-116286
Filing Date
2021-04-14
Accepted
2021-04-14 16:15:00
Documents
4
Period of Report
2021-05-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d937458ddef14a.htm DEF 14A 397442
2 GRAPHIC g937458g32q47.jpg GRAPHIC 42446
3 GRAPHIC g937458g57l46.jpg GRAPHIC 110684
4 GRAPHIC g937458g59b63.jpg GRAPHIC 188415
  Complete submission text file 0001193125-21-116286.txt   864708
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39509 | Film No.: 21825867
SIC: 2834 Pharmaceutical Preparations